Publications by authors named "K Oppong Asante"
Article Synopsis
- * Limited monitoring of air quality and rapid urbanization contribute to significant health risks from particulate matter, disproportionately affecting vulnerable populations.
- * Recommendations for tackling the issue include adopting air quality standards, improving renewable energy sources, and prioritizing environmental policies to protect public health during ongoing industrialization.
Article Synopsis
- The Ghana Randomized Air Pollution and Health Study (GRAPHS) analyzed the impact of daily maximum shaded wet bulb globe temperature (WBGTmax) and heat index (HImax) on aspects like birth weight and gestational age in pregnant individuals from 2013 to 2015 in Ghana.
- Results indicated that higher WBGTmax in specific trimesters affected newborn characteristics differently, with higher temperatures linked to increased head circumference but adverse effects on birth weight and length, highlighting the importance of monitoring temperature variations during pregnancy.
Evaluating the effectiveness and cost-effectiveness of integrating mass drug administration for helminth control with seasonal malaria chemoprevention in Ghanaian children: Protocol for a cluster randomised controlled trial.
Trop Med Int Health
November 2024
Objectives: To evaluate the effectiveness and cost-effectiveness of integrating seasonal malaria chemoprevention (SMC) with mass drug administration for helminth control among school-aged children living in communities where the burden of malaria and helminths is high in Ghana, West Africa.
Methods: This cluster randomised controlled trial will enrol 1200 children aged 5-10 years. Eligible children randomised to intervention clusters will receive SMC drugs (sulphadoxine-pyrimethamine plus amodiaquine) and anthelminthic drugs for soil-transmitted helminths-(albendazole), and for schistosomiasis (praziquantel), while children randomised to control clusters will receive SMC drugs alone.
Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030.
EBioMedicine
December 2024
Background: To date, global priorities for new vaccine R&D have not been systematically identified for endemic pathogens. As part of Immunisation Agenda 2030 (IA2030), we have systematically identified priority endemic pathogens for new vaccine R&D based on country and regional stakeholder values to address this need.
Methods: MCDA surveys targeting policy makers and immunisation stakeholders in each World Health Organization (WHO) region were used to weight eight criteria for prioritisation.